SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about financial results

24 May 2019 Evaluate

GlaxoSmithKline Pharmaceuticals has informed about Audited Financial Results Publication for Quarter & year ended 31st March 2019.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2581.00 14.45 (0.56%)
06-Aug-2026 14:11 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1951.00
Dr. Reddys Labs. 1170.25
Cipla 1475.80
Lupin 2391.30
Zydus Lifesciences 1106.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: